Our Story
LexBio pioneers a new era in drug discovery by harnessing the power of Artificial Intelligence (AI) to revolutionize the process of identifying and developing life-changing medicines. Our mission is to expedite the identification of novel therapeutic candidates with unparalleled efficiency and ingenuity.
Li Xing, Ph.D., Founder & CEO：
www.linkedin.com/in/li-xing-667b483/
scholar.google.com/citations?user=bSpJyLEAAAAJ&hl=en
Advisory Board
Founder& Chief Executive Officer of Ascentage Pharma
20+ years of senior executive and entrepreneurship experience
Head of Novartis China R&D Center
Teams
Our interdisciplinary teams in Suzhou, Shanghai and Boston consist of AI experts, data scientists, software engineers, biologists, computational and medicinal chemists.
Partnerships
|
|